Instant International
Written by: He Wenhan
2021-07-10 15:10
Last update date: 2021-07-10 15:10
The European Medicines Agency (EMA) said on July 9 that vaccination of the new coronavirus pneumonia (COVID-19) vaccines from the US pharmaceutical companies Pfizer and Moderna is associated with a very rare heart Inflammation may be related and requires pharmaceutical companies to list myocarditis and pericarditis as side effects of the vaccine.
Pfizer’s vaccine is jointly developed by Pfizer and BioNTech.
Both Pfizer's vaccine and Modena's vaccine use messenger ribonucleic acid (mRNA) technology.
New crown pneumonia epidemic in Sri Lanka: The picture shows a Sri Lankan soldier injecting the new crown pneumonia vaccine for the elderly at the vaccination center in the capital Colombo on July 7.
(AP)
The European Medicines Agency reviewed more than 300 cases of myocarditis and pericarditis in the European Union, Iceland, Norway, and Liechtenstein. Most of the patients were vaccinated against Pfizer.
According to the Safety Committee of the Drug Administration, the relevant cases mainly occurred within 14 days after vaccination, usually after the second dose of vaccination, and in younger adult men.
The safety committee emphasized that the benefits of "all approved vaccines" still outweigh the risks.
New crown pneumonia | The United States added warning words to Pfizer and Modena vaccines may cause heart inflammation
AstraZeneca vaccine | South Korea identified a death case related to COVID-19 vaccination
New crown vaccine｜Novavax vaccine has an effective rate of 90.4% and plans to apply for authorization
Covid-19 vaccine side effects Covid-19 vaccine vaccine Covid-19 Pfizer Modena myocarditis